Last updated: May 11, 2022
Sponsor: University of California, San Diego
Overall Status: Active - Recruiting
Phase
N/A
Condition
Glycogen Storage Disease (Gsd)
Treatment
N/AClinical Study ID
NCT03766386
170727
Ages < 100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
• Living or deceased patients with a diagnosis of Danon disease(including patients who mayor may not have undergone heart transplantation) based on a genetic test positive for theLAMP2 mutation
Exclusion
Exclusion Criteria:
• Patients without a genetic test positive for a LAMP2 mutation
Study Design
Total Participants: 200
Study Start date:
November 30, 2018
Estimated Completion Date:
November 30, 2024
Study Description
Connect with a study center
University of California, San Diego
San Diego, California 92122-5671
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.